New Jersey Cancer Care Joins Regional Cancer Care Associates
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and
Recent research has caused many healthcare professionals to reconsider their approach to screening men for prostate cancer. That’s because the
Research is ongoing to develop innovative treatments for cancers and blood disorders. Treating these diseases can be challenging, as they
New Jersey is home to some of the nation’s leading oncologists and hematologists, many of whom practice at Regional Cancer
Bleeding disorders are a group of hematologic conditions that occur when blood is unable to clot properly. The inability to
Two Connecticut-based medical oncologists at Regional Cancer Care Associates (RCCA) have been included in the 2024 edition of the prestigious
Prostate cancer affects more American men than any other cancer, with the exception of skin cancer. In addition to the
Anemia occurs when the body does not have enough healthy red blood cells to carry an adequate amount of oxygen
Surgery, chemotherapy, and radiation long have been mainstays of cancer treatment, but they aren’t the only options for people with
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.